Access cutting-edge lung cancer treatment through this clinical trial at a research site in Hastings. Study-provided care at no cost to qualified participants.
Access lung cancer specialists in Hastings at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lung cancer treatment provided free
This is a Phase 2/3, multisite, randomized, open-label study in participants with first-line non-small cell lung cancer (NSCLC). This study includes two substudies (substudy A and substudy B) that will recruit participants according to histological subtypes due to differences in chemotherapy choice for standard-of-care and type of NSCLC.
Sponsor: BioNTech SE
Check if you qualify for this lung cancer clinical trial in Hastings, NE
If you're searching for lung cancer treatment options in Hastings, NE, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Hastings research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.